private:alloyventures
|
87395
|
May 22nd, 2019 12:00AM
|
Alloy Ventures
|
714
|
12.00
|
Open
|
Venture Capital & Private Equity
|
May 21st, 2019 10:23PM
|
May 21st, 2019 10:23PM
|
Alloy Ventures is an early-stage venture capital firm with over $1 billion under management that invests in the entrepreneurs creating the next generation of ground-breaking Information Technology, Life Sciences, and Cleantech companies.
For the last 30 years, Alloy has leveraged the operational experience, extensive networks and forward-thinking vision of its partners to help start and build over 200 market-leading companies in fields such as software, semiconductors, mobile, medical devices, diagnostics, and laboratory instrumentation. Some of our successful investments include Amgen, AMCC, Applied Biosystems, Aspect Communications, CV Therapeutics, IDEC Pharmaceuticals, Nuance Communications, Octel, PMC-Sierra, Red Brick Systems, Remedy, and Verity – and our current portfolio includes companies like Barrx, Molecular Imprints, Optimedica, Pacific Biosciences, and Vivotech which are poised to become the next global leaders.
|
Open
|
venture capital, early-stage, IT, biotech, life sciences, cleantech, greentech, high tech, internet, ecommerce, semiconductor, laboratory tools, medical devices, solar, entrepreneurs, investing
|
Open
|
400 Hamilton Avenue
|
Palo Alto
|
CA
|
US
|
94301
|
|
Alloy Ventures
|
|
Financial Services
|
private:alloyventures
|
87395
|
Mar 18th, 2018 12:00AM
|
Alloy Ventures
|
679
|
12.00
|
Open
|
Venture Capital & Private Equity
|
Mar 18th, 2018 05:23PM
|
Mar 18th, 2018 05:23PM
|
|
Open
|
|
|
|
|
|
|
|
|
Alloy Ventures
|
|
Financial Services
|
private:alloyventures
|
87395
|
Feb 17th, 2018 12:00AM
|
Alloy Ventures
|
673
|
12.00
|
Open
|
Venture Capital & Private Equity
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Alloy Ventures is an early-stage venture capital firm with over $1 billion under management that invests in the entrepreneurs creating the next generation of ground-breaking Information Technology, Life Sciences, and Cleantech companies.
For the last 30 years, Alloy has leveraged the operational experience, extensive networks and forward-thinking vision of its partners to help start and build over 200 market-leading companies in fields such as software, semiconductors, mobile, medical devices, diagnostics, and laboratory instrumentation. Some of our successful investments include Amgen, AMCC, Applied Biosystems, Aspect Communications, CV Therapeutics, IDEC Pharmaceuticals, Nuance Communications, Octel, PMC-Sierra, Red Brick Systems, Remedy, and Verity – and our current portfolio includes companies like Barrx, Molecular Imprints, Optimedica, Pacific Biosciences, and Vivotech which are poised to become the next global leaders.
|
|
|
|
|
|
|
|
|
|
Alloy Ventures
|
|
Financial Services
|
private:alloyventures
|
87395
|
Feb 16th, 2018 12:00AM
|
Alloy Ventures
|
673
|
12.00
|
Open
|
Venture Capital & Private Equity
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Alloy Ventures is an early-stage venture capital firm with over $1 billion under management that invests in the entrepreneurs creating the next generation of ground-breaking Information Technology, Life Sciences, and Cleantech companies.
For the last 30 years, Alloy has leveraged the operational experience, extensive networks and forward-thinking vision of its partners to help start and build over 200 market-leading companies in fields such as software, semiconductors, mobile, medical devices, diagnostics, and laboratory instrumentation. Some of our successful investments include Amgen, AMCC, Applied Biosystems, Aspect Communications, CV Therapeutics, IDEC Pharmaceuticals, Nuance Communications, Octel, PMC-Sierra, Red Brick Systems, Remedy, and Verity – and our current portfolio includes companies like Barrx, Molecular Imprints, Optimedica, Pacific Biosciences, and Vivotech which are poised to become the next global leaders.
|
|
|
|
|
|
|
|
|
|
Alloy Ventures
|
|
Financial Services
|
private:alloyventures
|
87395
|
Feb 15th, 2018 12:00AM
|
Alloy Ventures
|
673
|
12.00
|
Open
|
Venture Capital & Private Equity
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Alloy Ventures is an early-stage venture capital firm with over $1 billion under management that invests in the entrepreneurs creating the next generation of ground-breaking Information Technology, Life Sciences, and Cleantech companies.
For the last 30 years, Alloy has leveraged the operational experience, extensive networks and forward-thinking vision of its partners to help start and build over 200 market-leading companies in fields such as software, semiconductors, mobile, medical devices, diagnostics, and laboratory instrumentation. Some of our successful investments include Amgen, AMCC, Applied Biosystems, Aspect Communications, CV Therapeutics, IDEC Pharmaceuticals, Nuance Communications, Octel, PMC-Sierra, Red Brick Systems, Remedy, and Verity – and our current portfolio includes companies like Barrx, Molecular Imprints, Optimedica, Pacific Biosciences, and Vivotech which are poised to become the next global leaders.
|
|
|
|
|
|
|
|
|
|
Alloy Ventures
|
|
Financial Services
|
private:alloyventures
|
87395
|
Feb 14th, 2018 12:00AM
|
Alloy Ventures
|
673
|
12.00
|
Open
|
Venture Capital & Private Equity
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Alloy Ventures is an early-stage venture capital firm with over $1 billion under management that invests in the entrepreneurs creating the next generation of ground-breaking Information Technology, Life Sciences, and Cleantech companies.
For the last 30 years, Alloy has leveraged the operational experience, extensive networks and forward-thinking vision of its partners to help start and build over 200 market-leading companies in fields such as software, semiconductors, mobile, medical devices, diagnostics, and laboratory instrumentation. Some of our successful investments include Amgen, AMCC, Applied Biosystems, Aspect Communications, CV Therapeutics, IDEC Pharmaceuticals, Nuance Communications, Octel, PMC-Sierra, Red Brick Systems, Remedy, and Verity – and our current portfolio includes companies like Barrx, Molecular Imprints, Optimedica, Pacific Biosciences, and Vivotech which are poised to become the next global leaders.
|
|
|
|
|
|
|
|
|
|
Alloy Ventures
|
|
Financial Services
|
private:alloyventures
|
87395
|
Feb 13th, 2018 12:00AM
|
Alloy Ventures
|
673
|
12.00
|
Open
|
Venture Capital & Private Equity
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Alloy Ventures is an early-stage venture capital firm with over $1 billion under management that invests in the entrepreneurs creating the next generation of ground-breaking Information Technology, Life Sciences, and Cleantech companies.
For the last 30 years, Alloy has leveraged the operational experience, extensive networks and forward-thinking vision of its partners to help start and build over 200 market-leading companies in fields such as software, semiconductors, mobile, medical devices, diagnostics, and laboratory instrumentation. Some of our successful investments include Amgen, AMCC, Applied Biosystems, Aspect Communications, CV Therapeutics, IDEC Pharmaceuticals, Nuance Communications, Octel, PMC-Sierra, Red Brick Systems, Remedy, and Verity – and our current portfolio includes companies like Barrx, Molecular Imprints, Optimedica, Pacific Biosciences, and Vivotech which are poised to become the next global leaders.
|
|
|
|
|
|
|
|
|
|
Alloy Ventures
|
|
Financial Services
|
private:alloyventures
|
87395
|
Feb 12th, 2018 12:00AM
|
Alloy Ventures
|
673
|
12.00
|
Open
|
Venture Capital & Private Equity
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Alloy Ventures is an early-stage venture capital firm with over $1 billion under management that invests in the entrepreneurs creating the next generation of ground-breaking Information Technology, Life Sciences, and Cleantech companies.
For the last 30 years, Alloy has leveraged the operational experience, extensive networks and forward-thinking vision of its partners to help start and build over 200 market-leading companies in fields such as software, semiconductors, mobile, medical devices, diagnostics, and laboratory instrumentation. Some of our successful investments include Amgen, AMCC, Applied Biosystems, Aspect Communications, CV Therapeutics, IDEC Pharmaceuticals, Nuance Communications, Octel, PMC-Sierra, Red Brick Systems, Remedy, and Verity – and our current portfolio includes companies like Barrx, Molecular Imprints, Optimedica, Pacific Biosciences, and Vivotech which are poised to become the next global leaders.
|
|
|
|
|
|
|
|
|
|
Alloy Ventures
|
|
Financial Services
|
private:alloyventures
|
87395
|
Feb 11th, 2018 12:00AM
|
Alloy Ventures
|
673
|
12.00
|
Open
|
Venture Capital & Private Equity
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Alloy Ventures is an early-stage venture capital firm with over $1 billion under management that invests in the entrepreneurs creating the next generation of ground-breaking Information Technology, Life Sciences, and Cleantech companies.
For the last 30 years, Alloy has leveraged the operational experience, extensive networks and forward-thinking vision of its partners to help start and build over 200 market-leading companies in fields such as software, semiconductors, mobile, medical devices, diagnostics, and laboratory instrumentation. Some of our successful investments include Amgen, AMCC, Applied Biosystems, Aspect Communications, CV Therapeutics, IDEC Pharmaceuticals, Nuance Communications, Octel, PMC-Sierra, Red Brick Systems, Remedy, and Verity – and our current portfolio includes companies like Barrx, Molecular Imprints, Optimedica, Pacific Biosciences, and Vivotech which are poised to become the next global leaders.
|
|
|
|
|
|
|
|
|
|
Alloy Ventures
|
|
Financial Services
|
private:alloyventures
|
87395
|
Feb 10th, 2018 12:00AM
|
Alloy Ventures
|
673
|
12.00
|
Open
|
Venture Capital & Private Equity
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Alloy Ventures is an early-stage venture capital firm with over $1 billion under management that invests in the entrepreneurs creating the next generation of ground-breaking Information Technology, Life Sciences, and Cleantech companies.
For the last 30 years, Alloy has leveraged the operational experience, extensive networks and forward-thinking vision of its partners to help start and build over 200 market-leading companies in fields such as software, semiconductors, mobile, medical devices, diagnostics, and laboratory instrumentation. Some of our successful investments include Amgen, AMCC, Applied Biosystems, Aspect Communications, CV Therapeutics, IDEC Pharmaceuticals, Nuance Communications, Octel, PMC-Sierra, Red Brick Systems, Remedy, and Verity – and our current portfolio includes companies like Barrx, Molecular Imprints, Optimedica, Pacific Biosciences, and Vivotech which are poised to become the next global leaders.
|
|
|
|
|
|
|
|
|
|
Alloy Ventures
|
|
Financial Services
|